Optibrium, a leading developer of software and AI solutions for drug discovery, has signed a license agreement for its AI-powered discovery platform, Cerella ™, with FMC Corporation (FMC), a global ...
Vincent Andrews, an analyst from Morgan Stanley, maintained the Hold rating on FMC (FMC – Research Report). The associated price target is $70.00. Vincent Andrews has given his Hold rating due to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback